Acromegaly: clinical features at diagnosis

Melmed S (2006) Acromegaly. N Engl J Med 355(24):2558–2573

Katznelson L, Laws ER Jr, Melmed S, Molitch ME, Murad MH, Utz A, Wass JA, Endocrine Society (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951

Borson-Chazot F, Garby L, Raverot G, Claustrat F, Raverot V, Sassolas G, GTE Group (2012) Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery. Ann Endocrinol 73(6):497–502

Melmed S, Ezrin K, Kovacs K, Goodman RS, Frohman LA (1985) Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor. N Engl J Med 312(1):9–17

Beuschlein F, Strasburger CJ, Siegerstetter V, Moradpour D, Lichter P, Bidlingmaier M, Blum HE, Reincke M (2000) Acromegaly caused by secretion of growth hormone by a non-Hodgkin’s lymphoma. N Engl J Med 342(25):1871–1876

Rostomyan L, Daly AF, Petrossians P, Nachev E, Lila AR, Lecoq AL, Lecumberri B, Trivellin G, Salvatori R, Moraitis AG, Holdaway I, Kranenburg-van Klaveren DJ, Chiara Zatelli M, Palacios N, Nozieres C, Zacharin M, Ebeling T, Ojaniemi M, Rozhinskaya L, Verrua E, Jaffrain-Rea ML, Filipponi S, Gusakova D, Pronin V, Bertherat J, Belaya Z, Ilovayskaya I, Sahnoun-Fathallah M, Sievers C, Stalla GK, Castermans E, Caberg JH, Sorkina E, Auriemma RS, Mittal S, Kareva M, Lysy PA, Emy P, De Menis E, Choong CS, Mantovani G, Bours V, De Herder W, Brue T, Barlier A, Neggers SJ, Zacharieva S, Chanson P, Shah NS, Stratakis CA, Naves LA, Beckers A (2015) Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr Relat Cancer 22(5):745–757

Capatina C, Wass JA (2015) 60 years of neuroendocrinology: acromegaly. J Endocrinol 226:T141–T160

Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong CS, Caberg JH, Verrua E, Naves LA, Cheetham TD, Young J, Lysy PA, Petrossians P, Cotterill A, Shah NS, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barra GB, Casulari LA, Neggers SJ, Salvatori R, Jaffrain-Rea ML, Zacharin M, Santamaria BL, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville JF, Quezado M, Chittiboina P, Oldfield EH, Bours V, Liu P, de Herder WW, Pellegata N, Lupski JR, Daly AF, Stratakis CA (2015) X-linked acrogigantism syndrome: clinical profile and therapeutic responses. Endocr Relat Cancer 22(3):353–367

Naves LA, Daly AF, Dias LA, Yuan B, Zakir JC, Barra GB, Palmeira L, Villa C, Trivellin G, Júnior AJ, Neto FF, Liu P, Pellegata NS, Stratakis CA, Lupski JR, Beckers A (2016) Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome. Endocrine 51(2):236–244

Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenický P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA (2014) Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371(25):2363–2374

Daly AF, Yuan B, Fina F, Caberg JH, Trivellin G, Rostomyan L, de Herder WW, Naves LA, Metzger D, Cuny T, Rabl W, Shah N, Jaffrain-Rea ML, Zatelli MC, Faucz FR, Castermans E, Nanni-Metellus I, Lodish M, Muhammad A, Palmeira L, Potorac I, Mantovani G, Neggers S, Klein M, Barlier A, Liu P, Ouafik L, Bours V, Lupski JR, Stratakis CA, Beckers A (2016) Somatic mosaicism underlies X-linked acrogigantism (XLAG) syndrome in sporadic male subjects. Endocr Relat Cancer 23(4):221–233

Salenave S, Boyce AM, Collins MT, Chanson P (2014) Acromegaly and McCune-Albright syndrome. J Clin Endocrinol Metab 99(6):1955–1969

Turan S, Bastepe M (2015) GNAS spectrum of disorders. Curr Osteoporos Rep 13(3):146–158

Holdaway IM, Rajasoorya C (1999) Epidemiology of acromegaly. Pituitary 2(1):29–41

Etxabe J, Gaztambide S, Latorre P, Vazquez JA (1993) Acromegaly: an epidemiological study. J Endocrinol Invest 16(3):181–187

Molitch ME (1992) Clinical manifestations of acromegaly. Clin Endocrinol Metab 21:597–614

Daughaday WH (1992) Pituitary gigantism. Endocrinol Metab Clin North Am 21(3):633–647

Nabarro JD (1987) Acromegaly. Clin Endocrinol 26(4):481–512

Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol 72(2):203–208

Chanson P, Salenave S (2008) Acromegaly. Orphanet J Rare Dis 3:17

Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine 73(5):233–240

Melmed S, Kleinberg D (2003) Anterior pituitary. In: Reed Larsen P, Kronemberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology, 10th edn. Saunders, Philadelphia, pp 177–280

Castro Cabezas M, Zelissen PM, Jansen GH, Van Gils AP, Koppeschaar HP (1999) Acromegaly: report of two patients with an unusual presentation. Neth J Med 54(4):163–166

Naves LA, Mercado M, Duarte FG, Vilar BF, Vilar L (2016) Acromegaly—an overview. In: Vilar L (ed) Endocrinologia Clinica (Clinical endocrinology), 6th edn. Guanabara Koogan, Rio de Janeiro, pp 56–70

Daita G, Yonemasu Y, Hashizume A (1987) Unilateral exophthalmos caused by an invasive pituitary adenoma. Neurosurgery. Neurosurgery 21(5):716–718

Vilar L, Fleseriu M, Bronstein MD (2014) Challenges and pitfalls in the diagnosis of hyperprolactinemia. Arq Bras Endocrinol Metabol 58(1):9–22

Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, Barros AI, Faria M, Nascimento GC, Lima JG, Nóbrega LH, Cruz TP, Mota A, Ramos A, Violante A, Lamounier Filho A, Gadelha MR, Czepielewski MA, Glezer A, Bronstein MD (2008) Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest 31(5):436–444

Vilar L, Czepielewski MA, Naves LA, Rollin GA, Casulari LA, Coelho CE (2007) Substantial shrinkage of adenomas cosecreting growth hormone and prolactin with use of cabergoline therapy. Endocr Pract 13(4):396–402

Freda PU, Reyes CM, Nuruzzaman AT, Sundeen RE, Khandji AG, Post KD (2004) Cabergoline therapy of growth hormone & growth hormone/prolactin secreting pituitary tumors. Pituitary 7(1):21–30

van der Lely AJ, Beckers A, Daly AF, Lamberts SWJ, Clemmons DR (eds) (2005) Acromegaly—pathology, diagnosis and treatment. Taylor and Francis Group, Boca Raton

Ben-Shlomo MS (2006) Skin manifestations in acromegaly. Clin Dermatol 24(4):256–259

Akoglu G, Metin A, Emre S, Ersoy R, Cakir B (2013) Cutaneous findings in patients with acromegaly. Acta Dermatovenerol Croat 21(4):224–229

Jain R, Dutta D, Shivaprasad K, Maisnam I, Ghosh S, Mukhopadhyay S, Chowdhury S (2012) Acromegaly presenting as hirsutism: uncommon sinister aetiology of a common clinical sign. Indian J Endocrinol Metab 16(Suppl 2):S297–S299

Miller A, Doll H, David J, Wass J (2008) Impact of musculoskeletal disease on quality of life in long-standing acromegaly. Eur J Endocrinol 158(5):587–593

Kropf LL, Madeira M, Neto LV, Gadelha MR, de Farias ML (2013) Functional evaluation of the joints in acromegalic patients and associated factors. Clin Rheumatol 32(7):991–998

Lieberman SA, Björkengren AG, Hoffman AR (1992) Rheumatologic and skeletal changes in acromegaly. Endocrinol Metab Clin North Am 21(3):615–631

Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, Giampietro A, De Marinis L, Giustina A (2013) Vertebral fractures in patients with acromegaly: a 3-year prospective study. J Clin Endocrinol Metab 98(8):3402–3410

Wassenaar MJ, Biermasz NR, Hamdy NA, Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Uitterlinden AG, Stokkel MP, Roelfsema F, Kloppenburg M, Kroon HM, Romijn JA, Pereira AM (2011) High prevalence of vertebral fractures despite normal bone mineral density in patients with long-term controlled acromegaly. Eur J Endocrinol 164(4):475–483

Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102–152

Zoicas F, Kleindienst A, Mayr B, Buchfelder M, Megele R, Schöfl C (2016) Screening for acromegaly in patients with carpal tunnel syndrome: a prospective study (ACROCARP). Horm Metab Res 48(7):452–456

Webb SM (2006) Quality of life in acromegaly. Neuroendocrinology 83(3–4):224–229

Dantas RA, Passos KE, Porto LB, Zakir JC, Reis MC, Naves LA (2013) Physical activities in daily life and functional capacity compared to disease activity control in acromegalic patients: impact in self-reported quality of life. Arq Bras Endocrinol Metabol 57(7):550–557

Abreu A, Tovar AP, Castellanos R, Valenzuela A, Giraldo CM, Pinedo AC, Guerrero DP, Barrera CA, Franco HI, Ribeiro-Oliveira A Jr, Vilar L, Jallad RS, Duarte FG, Gadelha M, Boguszewski CL, Abucham J, Naves LA, Musolino NR, de Faria ME, Rossato C, Bronstein MD (2016) Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 19(4):448–457

van Haute FR, Taboada GF, Corrêa LL, Lima GA, Fontes R, Riello AP, Dominici M, Gadelha MR (2008) Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging. Eur J Endocrinol 158(4):459–465

Rodrigues MP, Naves LA, Casulari LA, Silva CA, Araújo RR, Viegas CA (2007) Using clinical data to predict sleep hypoxemia in patients with acromegaly. Arq Neuropsiquiatr 65(2A):234–239

Møller N, Jørgensen JO, Abildgard N, Orskov L, Schmitz O, Christiansen JS (1991) Effects of growth hormone on glucose metabolism. Horm Res 36(Suppl 1):32–35

Espinosa-de-los-Monteros AL, González B, Vargas G, Sosa E, Mercado M (2011) Clinical and biochemical characteristics of acromegalic patients with different abnormalities in glucose metabolism. Pituitary 14(3):231–235

Vilar L, Naves LA, Costa SS, Abdalla LF, Coelho CE (2007) Increase of classic and nonclassic cardiovascular risk factors in patients with acromegaly. Endocr Pract 13(4):363–372

Dreval AV, Trigolosova IV, Misnikova IV, Kovalyova YA, Tishenina RS, Barsukov IA, Vinogradova AV, Wolffenbuttel BH (2014) Prevalence of diabetes mellitus in patients with acromegaly. Endocr Connect 3(2):93–98

Bondanelli M, Ambrosio MR, degli Uberti EC (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary 4(4):239–249

Mosca S, Paolillo S, Colao A, Bossone E, Cittadini A, Iudice FL, Parente A, Conte S, Rengo G, Leosco D, Trimarco B, Filardi PP (2013) Cardiovascular involvement in patients affected by acromegaly: an appraisal. Int J Cardiol 167(5):1712–1718

dos Santos Silva CM, Gottlieb I, Volschan I, Kasuki L, Warszawski L, Balarini Lima GA, Xavier SS, Pedrosa RC, Neto LV, Gadelha MR (2015) Low frequency of cardiomyopathy using cardiac magnetic resonance imaging in an acromegaly contemporary cohort. J Clin Endocrinol Metab 100(12):4447–4455

Bihan H, Espinosa C, Valdes-Socin H, Salenave S, Young J, Levasseur S, Assayag P, Beckers A, Chanson P (2004) Long-term outcome of patients with acromegaly and congestive heart failure. J Clin Endocrinol Metab 89(11):5308–5313

Fava GA, Sonino N, Morphy MA (1993) Psychosomatic view of endocrine disorders. Psychother Psychosom 59(1):20–33

Yedinak CG, Fleseriu M (2014) Self-perception of cognitive function among patients with active acromegaly, controlled acromegaly, and non-functional pituitary adenoma: a pilot study. Endocrine 46(3):585–593

Manara R, Maffei P, Citton V, Rizzati S, Bommarito G, Ermani M, Albano I, Della Puppa A, Carollo C, Pavesi G, Scanarini M, Ceccato F, Sicolo N, Mantero F, Scaroni C, Martini C (2011) Increased rate of intracranial saccular aneurysms in acromegaly:an MR angiography study and review of the literature. J Clin Endocrinol Metab 96(5):1292–1300

Manara R, Bommarito G, Rizzati S, Briani C, Della Puppa A, Citton V, Zanchetta E, Zerbo F, Ermani M, Martini C, Mantero F, Sicolo N, Maffei P, Scaroni C (2013) Herniation of cerebellar tonsils in acromegaly: prevalence, pathogenesis and clinical impact. Pituitary 16(1):122–130

Carvalho MA, Montenegro RM Jr, Freitas MR, Vilar L, Mendonca AT, Montenegro RM (2012) Sensorineural hearing loss in acromegalic patients under treatment. Braz J Otorhinolaryngol 78(4):98–102

Glezer A, Bronstein MD (2015) Pituitary apoplexy: pathophysiology, diagnosis and management. Arch Endocrinol Metab 59(3):259–264

Fraser LA, Lee D, Cooper P, Van Uum S (2009) Remission of acromegaly after pituitary apoplexy: case report and review of literature. Endocr Pract 15(7):725–731

Renehan AG, O’Connell J, O’Halloran D, Shanahan F, Potten CS, O’Dwyer ST, Shalet SM (2003) Acromegaly and colorectal cancer: a comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 35:712–725

Dutta P, Bhansali A, Vaiphei K, Dutta U, Ravi Kumar P, Masoodi S, Mukherjee KK, Varma A, Kochhar R (2012) Colonic neoplasia in acromegaly: increased proliferation or deceased apoptosis? Pituitary 15(2):166–173

Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 83(8):2730–2734

Wolinski K, Czarnywojtek A, Ruchala M (2014) Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly–meta-analysis and systematic review. PLoS ONE 9(2):e88787

Reverter JL, Fajardo C, Resmini E, Salinas I, Mora M, Llatjós M, Sesmilo G, Rius F, Halperin I, Webb SM, Ricart V, Riesgo P, Mauricio D, Puig-Domingo M (2014) Benign and malignant nodular thyroid disease in acromegaly. Is a routine thyroid ultrasound evaluation advisable? PLoS ONE 9(8):e104174

dos Santos MC, Nascimento GC, Nascimento AG, Carvalho VC, Lopes MH, Montenegro R, Montenegro R Jr, Vilar L, Albano MF, Alves AR, Parente CV, dos Santos Faria M (2013) Thyroid cancer in patients with acromegaly: a case-control study. Pituitary 16(1):109–114

Gullu BE, Celik O, Gazioglu N, Kadioglu P (2010) Thyroid cancer is the most common cancer associated with acromegaly. Pituitary 13(3):242–248

Rogozinski A, Furioso A, Glikman P, Junco M, Laudi R, Reyes A, Lowenstein A (2012) Thyroid nodules in acromegaly. Arq Bras Endocrinol Metabol 56(5):300–304

Boguszewski CL, Ayuk J (2016) Management of endocrine disease: acromegaly and cancer: an old debate revisited. Eur J Endocrinol 175(4):R147–R156

Mercado M, Gonzalez B, Vargas G, Ramirez C, de los Monteros AL, Sosa E, Jervis P, Roldan P, Mendoza V, López-Félix B, Guinto G (2014) Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic. J Clin Endocrinol Metab 99(12):4438–4446

Ritvonen E, Löyttyniemi E, Jaatinen P, Ebeling T, Moilanen L, Nuutila P, Kauppinen-Mäkelin R, Schalin-Jäntti C (2015) Mortality in acromegaly: a 20-year follow-up study. Endocr Relat Cancer 23(6):469–480

Rostomyan L, Daly AF, Beckers A (2015) Pituitary gigantism: causes and clinical characteristics. Ann Endocrinol 76(6):643–649

Hernández-Ramírez LC, Gabrovska P, Dénes J, Stals K, Trivellin G, Tilley D, Ferrau F, Evanson J, Ellard S, Grossman AB, Roncaroli F, Gadelha MR, Korbonits M, International FIPA Consortium (2015) Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J Clin Endocrinol Metab 100(9):E1242–E1254

Vasilev V, Daly A, Naves L, Zacharieva S, Beckers A (2012) Clinical and genetic aspects of familial isolated pituitary adenomas. Clinics 67(Suppl 1):37–41

Naves LA, Daly AF, Vanbellinghen JF, Casulari LA, Spilioti C, Magalhães AV, Azevedo MF, Giacomini LA, Nascimento PP, Nunes RO, Rosa JW, Jaffrain-Rea ML, Bours V, Beckers A (2007) Variable pathological and clinical features of a large Brazilian family harboring a mutation in the aryl hydrocarbon receptor-interacting protein gene. Eur J Endocrinol 157(4):383–391

Naves LA, Jaffrain-Rea ML, Vêncio SA, Jacomini CZ, Casulari LA, Daly AF, Beckers A (2010) Aggressive prolactinoma in a child related to germline mutation in the ARYL hydrocarbon receptorA195 V interacting protein (AIP) gene. Arq Bras Endocrinol Metabol 54(8):761–767

Molich ME (2009) Pituitary tumours: pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab 23(5):667–675

Clemmons DR, Chihara K, Freda PU, Ho KK, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO (2003) Optimizing control of acromegaly: integrating a growth hormone receptor. antagonist into the treatment algorithm. J Clin Endocrinol Metab 88(10):4759–4767

Anumah F, Danbauchi S, Garko S (2008) Acromegaly presenting as cardiac failure. Ethn Dis 18(1):104–106

Cooper T, Dziegielewski PT, Singh P, Seemann R (2015) Acromegaly presenting with bilateral vocal fold immobility: case report and review of the literature. J Voice. doi: 10.1016/j.jvoice.2015.09.008

Al-Bedaia M, Al-Khenaizan AS (2008) Acromegaly presenting as cutis verticis gyrata. Int J Dermatol 47(2):164

Westphal SA (2000) Concurrent diagnosis of acromegaly and diabetic ketoacidosis. Endocr Pract 6(6):450–452

Sidhaye A, Burger P, Rigamonti D, Salvatori R (2005) Giant somatotrophinoma without acromegalic features: more “quiet” than “silent”: case report. Neurosurgery 56(5):E1154 (discussion E1154)

Melmed S, Casanueva FF, Klibanski A, Bronstein MD, Chanson P, Lamberts SW, Strasburger CJ, Wass JA, Giustina A (2013) A consensus on the diagnosis and treatment of acromegaly complications. Pituitary 16(3):294–302

Freda PU, Beckers AM, Katznelson L, Molitch ME, Montori VM, Post KD, Vance ML, Endocrine Society (2011) Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(4):894–904